The Microbial Path to Oncology Proteins

Oncology has become the largest and most dynamic therapeutic area in modern biopharma. The pipeline of protein-based cancer therapies, monoclonal antibodies, bispecifics, fusion proteins, therapeutic enzymes, recombinant cytokines, has expanded faster than any other therapeutic category over the past decade.

Growing More with Less Water:
The Microbial Answer to Arid-Zone Agriculture

The expansion of agriculture into arid and semi-arid regions is no longer a frontier ambition. It is an operational reality.

Regulatory maze:
how to navigate microbial approvals across regions?

Bringing a microbial product to market isn’t just a scientific challenge. It’s a regulatory one.

The microbiological revolution that is barely being noticed

Artificial intelligence may dominate the headlines, but another transformative revolution is quietly changing science, health, and industry: microbiology.

Proteins to fibers:
unlocking the next generation of bio-based materials

In microbial biotechnology, proteins are no longer confined to food, feed, or enzyme applications. They are becoming the foundation of a new class of materials-fibers engineered through microbial fermentation.

From phosphorus crisis to nitrogen efficiency:
the microbial fermentation opportunity

Phosphorus is essential to life, yet it’s non-renewable, inefficiently used, and dangerously overlooked.